Immunogenicity of infliximab in Crohn's disease

被引：0
|
作者：
Hanauer, SB [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2155 / 2156
页数：2
相关论文
共 50 条
  • [1] Immunogenicity of infliximab in Crohn's disease - Reply
    Rutgeerts, P
    Baert, F
    Noman, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (21): : 2156 - 2156
  • [2] Comparison of Techniques for Monitoring Infliximab Bioavailability and Immunogenicity in Crohn's Disease
    Steenholdt, Casper
    Svenson, Morten
    Ainsworth, Mark A.
    Thomsen, Ole.
    Brynskov, Jorn
    Bendtzen, Klaus
    GASTROENTEROLOGY, 2012, 142 (05) : S781 - S781
  • [3] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
    Baert, F
    Noman, M
    Vermeire, S
    Van Assche, G
    D'Haens, G
    Carbonez, A
    Rutgeerts, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07): : 601 - 608
  • [4] Infliximab monitoring in Crohn's disease: a neural network approach for evaluating disease activity and immunogenicity
    Miani Gomes, Luis Eduardo
    Genaro, Livia Moreira
    de Castro, Marina Moreira
    Ricci, Renato Lazarin
    Pascoal, Livia Bitencourt
    Crispim Silva, Filipe Botto
    Leite Bonfitto, Pedro Henrique
    Camargo, Michel Gardere
    Corona, Ligiana Pires
    Setsuko Ayrizono, Maria de Lourdes
    de Azevedo, Anibal Tavares
    Leal, Raquel Franco
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [5] Infliximab in Crohn's disease
    Sáez, LR
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 359 - 363
  • [6] Infliximab for Crohn's disease
    Verspaget, HW
    van der Zon, AM
    Gao, Q
    van Hogezand, RA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 2041 - 2042
  • [7] Incidence and Clinical Significance of Immunogenicity to Infliximab in Crohn's Disease: A Critical Systematic Review
    Cassinotti, Andrea
    Travis, Simon
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (08) : 1264 - 1275
  • [8] Immunogenicity after switching from reference infliximab to biosimilar in children with Crohn's disease
    Sieczkowska, J.
    Jarzebicka, D.
    Oracz, G.
    Meglicka, M.
    Dadalski, M.
    Kierkus, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S413 - S414
  • [9] Methotrexate protects against infliximab immunogenicity in azathioprine intolerant/ineligible Crohn's disease patients
    Kayal, DP
    Saeian, K
    Knox, JE
    Podoll, J
    Emmons, J
    Bajaj, JS
    Binion, DG
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S258 - S258
  • [10] Infliximab in paediatric Crohn's disease
    Feetham, Laura
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 11 - 11
12345